tiprankstipranks
20/20 Biolabs, Inc. (AIDX)
NASDAQ:AIDX
US Market
AIDX
20/20 Biolabs, Inc.
RESEARCH TOOLSreports
Want to see AIDX full AI Analyst Report?

20/20 Biolabs, Inc. (AIDX) Ratios

12 Followers

20/20 Biolabs, Inc. Ratios

AIDX's free cash flow for Q2 2026 was $0.42. For the 2026 fiscal year, AIDX's free cash flow was decreased by $ and operating cash flow was $-1.70. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.99 0.60 1.50 4.25 5.97
Quick Ratio
 1.95 -46.59 1.47 4.19 5.92
Cash Ratio
 1.78 416.54 1.32 4.04 5.40
Solvency Ratio
 -1.94 -0.88 -2.61 -2.99 0.87
Operating Cash Flow Ratio
 -1.09 -779.38 -1.92 -4.58 3.56
Short-Term Operating Cash Flow Coverage
 -14.49 -10.91 -15.68 -28.26 29.03
Net Current Asset Value
$ 2.11M$ -2.69M$ -44.70K$ 2.22M$ 6.89M
Leverage Ratios
Debt-to-Assets Ratio
 0.09 310.35 0.42 0.33 0.20
Debt-to-Equity Ratio
 0.18 -66.79K 0.99 0.48 0.26
Debt-to-Capital Ratio
 0.15 1.00 0.50 0.33 0.20
Long-Term Debt-to-Capital Ratio
 0.11 1.03 0.31 0.20 0.11
Financial Leverage Ratio
 1.94 -215.21 2.36 1.49 1.30
Debt Service Coverage Ratio
 -5.41 -0.02 -30.98 -32.31 9.13
Interest Coverage Ratio
 -6.34 -21.32 -447.66 -227.89 107.04
Debt to Market Cap
 0.08 1.18 <0.01 0.01 0.01
Interest Debt Per Share
 0.12 205.25 0.32 0.44 0.51
Net Debt to EBITDA
 0.83 -73.63 0.05 0.33 -3.25
Profitability Margins
Gross Profit Margin
31.52%29.56%20.56%7.66%46.31%
EBIT Margin
-238.46%-175.18%-323.06%-446.64%15.18%
EBITDA Margin
-235.10%-171.36%-315.31%-434.89%17.79%
Operating Profit Margin
-215.69%-162.87%-323.06%-446.64%15.18%
Pretax Profit Margin
-285.00%-182.82%-316.81%-448.73%19.77%
Net Profit Margin
-285.00%-182.82%-316.81%-448.73%19.77%
Continuous Operations Profit Margin
-285.00%-182.82%-316.81%-448.73%19.77%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
132.13%112.25%98.07%100.47%130.26%
Return on Assets (ROA)
-94.96%-90.37%-153.65%-100.37%17.90%
Return on Equity (ROE)
-387.27%19447.70%-361.86%-149.07%23.33%
Return on Capital Employed (ROCE)
-123.20%-198.95%-250.70%-118.77%15.86%
Return on Invested Capital (ROIC)
-116.89%-1.87%-233.56%-115.24%15.57%
Return on Tangible Assets
-98.26%1.89%-178.28%-109.42%19.04%
Earnings Yield
-96.22%-2.51%-4.85%-5.62%1.92%
Efficiency Ratios
Receivables Turnover
 7.00 0.01 12.95 20.69 14.46
Payables Turnover
 1.36 <0.01 3.74 3.65 12.79
Inventory Turnover
 12.58 0.01 29.51 21.68 68.19
Fixed Asset Turnover
 3.69 <0.01 1.97 1.21 6.62
Asset Turnover
 0.33 0.49 0.48 0.22 0.91
Working Capital Turnover Ratio
 0.88 -13.07 0.88 0.25 1.60
Cash Conversion Cycle
 -187.10 -154.93K -57.08 -65.51 2.06
Days of Sales Outstanding
 52.15 35.69K 28.18 17.64 25.25
Days of Inventory Outstanding
 29.01 29.45K 12.37 16.84 5.35
Days of Payables Outstanding
 268.26 220.06K 97.62 99.99 28.54
Operating Cycle
 81.16 65.13K 40.54 34.48 30.60
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.26 -306.83 -0.54 -0.97 1.22
Free Cash Flow Per Share
 -0.26 -306.83 -0.54 -0.97 1.16
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 0.05
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 0.95
Dividend Paid and CapEx Coverage Ratio
 -21.98 0.00 -519.76K -493.32 22.17
Capital Expenditure Coverage Ratio
 -521.43 0.00 -519.76K -493.32 22.17
Operating Cash Flow Coverage Ratio
 -4.88 -1.50 -1.72 -2.23 2.40
Operating Cash Flow to Sales Ratio
 -1.37 -938.68 -1.48 -3.25 0.52
Free Cash Flow Yield
-40.61%-1286.50%-2.27%-4.08%4.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.74 -39.75 -20.56 -17.80 51.95
Price-to-Sales (P/S) Ratio
 3.36 72.96 65.34 79.85 10.27
Price-to-Book (P/B) Ratio
 1.91 -7.76K 74.63 26.53 12.12
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.46 -0.08 -44.06 -24.52 20.50
Price-to-Operating Cash Flow Ratio
 -2.16 -0.08 -44.06 -24.57 19.58
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.82 1.53 0.05 11.43
Price-to-Fair Value
 1.91 -7.76K 74.63 26.53 12.12
Enterprise Value Multiple
 -0.60 -116.21 -20.67 -18.04 54.49
Enterprise Value
 2.89M 407.26M 114.22M 111.72M 107.22M
EV to EBITDA
 -0.60 -116.21 -20.67 -18.04 54.49
EV to Sales
 1.42 199.14 65.18 78.44 9.69
EV to Free Cash Flow
 -1.04 -0.21 -43.95 -24.09 19.35
EV to Operating Cash Flow
 -1.03 -0.21 -43.95 -24.14 18.48
Tangible Book Value Per Share
 0.27 -32.33 0.22 0.79 1.82
Shareholders’ Equity Per Share
 0.29 >-0.01 0.32 0.90 1.97
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.19 0.33 0.37 0.30 2.32
Net Income Per Share
 -0.54 -0.60 -1.16 -1.34 0.46
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.20 1.04 0.98 1.00 1.30
Research & Development to Revenue
 0.33 0.29 0.72 0.99 0.01
SG&A to Revenue
 2.14 1.63 2.72 0.00 0.00
Stock-Based Compensation to Revenue
 0.37 0.00 0.00 0.00 0.00
Income Quality
 0.48 0.51 0.47 0.72 2.65
Currency in USD